Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

20 Stocks Moving in Wednesday's Pre-Market Session

Gainers

  • Decisionpoint Systems, Inc. (NASDAQ:DPSI) rose 47.2% to $7.02 in pre-market trading after jumping around 19% on Tuesday. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.
  • National CineMedia, Inc. (NASDAQ:NCMI) rose 26.2% to $1.83 in pre-market trading. National CineMedia’s 13G Filing from AMC Entertainment showed a new 6.8% stake in the company.
  • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 18% to $0.7080 in pre-market trading after jumping over 25% on Tuesday. The company announced plans to offer new bundled robotic disinfection services in Mainland China.
  • DLocal Limited (NASDAQ:DLO) rose 13.6% to $21.88 in pre-market trading after the company reported better-than-expected Q1 sales results.
  • Enjoy Technology, Inc. (NASDAQ:ENJY) shares rose 13.2% to $0.40 in pre-market trading. Enjoy Technology shares dipped around 53% on Tuesday after the company reported worse-than-expected Q1 EPS and sales results.
  • GreenBox POS (NASDAQ:GBOX) rose 12.5% to $2.25 in pre-market trading after dipping 24% on Tuesday. The company recently reported a rise in quarterly sales.
  • Calliditas Therapeutics AB (NASDAQ:CALT) rose 10.7% to $16.82 in pre-market trading. The company recently posted Q1 net sales of SEK 49.7 million.
  • Hyzon Motors Inc. (NASDAQ:HYZN) rose 9.6% to $4.33 in pre-market trading. Hyzon Motors recently posted a Q1 loss of $0.03 per share.
  • uCloudlink Group Inc. (NASDAQ:UCL) shares rose 9.2% to $1.09 in pre-market trading after gaining more than 7% on Tuesday.
  • Armstrong Flooring, Inc. (NYSE:AFI) rose 8.6% to $0.32 in pre-market trading after receiving approval for additional financing.
  • Verb Technology Company, Inc.. (NASDAQ:VERB) rose 8.1% to $0.46 in pre-market trading after jumping around 30% on Tuesday.
  • CTI BioPharma Corp. (NASDAQ:CTIC) rose 6.8% to $4.70 in pre-market trading. CTI BioPharma recently posted a Q1 loss of $0.37 per share.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.